Compass Therapeutics, Inc. Banner Image

Compass Therapeutics, Inc.

  • Ticker CMPX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Compass Therapeutics, Inc. Logo Image
  • 11-50 Employees
  • Based in Boston, Massachusetts
Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass’ scientific focus is on the relationship between angiogenesis, the immune system and tumor growth. The company pipeline of novel product candidates is designed to target multiple critical biological pathwaysMore required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. Compass plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The company was founded in 2014 and is headquartered in Boston, Massachusetts.
3.0 / 5.0 (3)

Compass Therapeutics, Inc. reports have an aggregate usefulness score of 3.0 based on 3 reviews.

Compass Therapeutics, Inc.

Most Recent Annual Report

Compass Therapeutics, Inc.
MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

Compass Therapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!